Skip to main content

Table 2 Distribution of treatment regimens in the first episodes of 50 TB cases with a recurrence

From: Recurrent tuberculosis in Finland 1995–2013: a clinical and epidemiological cohort study

Treatment group

Total in group

Intensive phase short

Intensive phase adequate

Duration of treatment short

Duration of treatment adequate

Standard treatment Aa

15

NA

15

1

14

Standard treatment Bb

4

NA

4

2

2

Standard treatment with short intensive phase Cc

3

3

NA

2

1

Standard treatment Dd

14

0

14

1

13

Other probably effective combination of anti-TB drugse

6

NA

NA

1

5

Other probably ineffective combination of anti-TB drugsf

6

NA

NA

NA

NA

Not evaluated

2

  1. NA not applicable, H isoniazid, R Rifampicin, Z pyrazinamide, E ethambutol
  2. a HRZ in intensive phase, HR in continuation phase, adequate duration of treatment ≥  5.5 months
  3. b HRE in intensive phase, HR in continuation phase, adequate duration of treatment ≥ 8 months
  4. c Short intensive phase <54 days in standard treatment A or B
  5. d ≥  4 anti-TB drugs, including HRZ (adequate duration of treatment ≥ 5.5 months) or HRE (adequate duration of treatment ≥ 8 months)
  6. e Non-standard combinations guided by drug resistance or due to adverse effects, the adequacy of treatment duration assessed by the study group
  7. f Drug resistance ignored or inappropriate dosing
  8. References [9, 12, 13]